AI tool reveals how TB drugs kill bacteria at the molecular level

Tuberculosis (TB) is the world’s deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a cocktail of multiple drugs over at least six months, and one in five patients have a type of TB that resists these first-line medications.